Denosumab Versus Oral Bisphosphonate (Alendronate) for Osteoporosis in Long-term Glucocorticoid Users: an Open Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 10 Oct 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Aug 2019.
- 10 Oct 2017 Status changed from not yet recruiting to recruiting.
- 16 Apr 2017 Planned End Date changed from 1 Dec 2019 to 1 Feb 2020.